Showing 2801-2810 of 8873 results for "".
Expectations: Put it in Writing
https://practicaldermatology.com/topics/practice-management/expectations-put-it-in-writing/20521/Patients who have clear expectations and understand their role in their care and treatment are more engaged, more compliant, and are more likely to have better outcomes. It helps to get it in writing.Currents: Where Are the Cosmetic Dermatology Patients?
https://practicaldermatology.com/topics/practice-management/currents-where-are-the-cosmetic-dermatology-patients/20518/Five Ways to Turn Burnout into an Opportunity
https://practicaldermatology.com/topics/practice-management/five-ways-to-turn-burnout-into-an-opportunity/20559/A physician burnout coach offers real-life suggestions to confronting burnout.Enjoyable By Design
https://practicaldermatology.com/topics/practice-management/enjoyable-by-design/20560/Working in a properly designed space is one way to reduce stress and bring more enjoyment to daily practice.The Women's Dermatologic Society Takes Manhattan
https://practicaldermatology.com/topics/practice-management/the-womens-dermatologic-society-takes-manhattan/20579/WDS leaders educate the media on at-home beauty devices, pigment disorders, and more.Just Take a Knee and Sit this One Out
https://practicaldermatology.com/topics/practice-management/just-take-a-knee-and-sit-this-one-out/20569/Reduce Your Life Insurance Costs
https://practicaldermatology.com/topics/practice-management/reduce-your-life-insurance-costs/20630/You “refi” your mortgage when rates go down. Here are seven reasons to do the same for your life insurance.Psoriasis Wish List
https://practicaldermatology.com/topics/psoriasis/psoriasis-wish-list/20667/Clinical thought leaders share what they hope for to improve treatment in the future.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20654/Get Ready: The Biosimilars Are Here
https://practicaldermatology.com/topics/psoriasis/get-ready-the-biosimilars-are-here/20662/Recent developments mean that biosimilars are finally hitting the US market.